APLT Applied Therapeutics Inc

Price (delayed)

$1.36

Market cap

$35.68M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4

Enterprise value

-$1.31M

Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company's lead drug candidate, ...

Highlights
APLT's debt is down by 25% year-on-year and by 8% since the previous quarter
The company's EPS rose by 14% YoY and by 2.9% QoQ
The equity has dropped by 69% year-on-year and by 33% since the previous quarter
The quick ratio has dropped by 67% year-on-year and by 18% since the previous quarter

Key stats

What are the main financial stats of APLT
Market
Shares outstanding
26.24M
Market cap
$35.68M
Enterprise value
-$1.31M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.85
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$103.97M
EBITDA
-$103.55M
Free cash flow
-$92.93M
Per share
EPS
-$4
Free cash flow per share
-$3.54
Book value per share
$1.6
Revenue per share
$0
TBVPS
$2.48
Balance sheet
Total assets
$64.95M
Total liabilities
$22.99M
Debt
$1.23M
Equity
$41.96M
Working capital
$41.35M
Liquidity
Debt to equity
0.03
Current ratio
2.86
Quick ratio
2.5
Net debt/EBITDA
0.36
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-101.9%
Return on equity
-137.7%
Return on invested capital
-575.9%
Return on capital employed
-243.3%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

APLT stock price

How has the Applied Therapeutics stock price performed over time
Intraday
3.82%
1 week
29.52%
1 month
44.19%
1 year
-92.55%
YTD
-84.8%
QTD
43.43%

Financial performance

How have Applied Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$104.52M
Net income
-$104.53M
Gross margin
N/A
Net margin
N/A

Growth

What is Applied Therapeutics's growth rate over time

Valuation

What is Applied Therapeutics stock price valuation
P/E
N/A
P/B
0.85
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 14% YoY and by 2.9% QoQ
APLT's price to book (P/B) is 78% less than its last 4 quarters average of 3.7
The equity has dropped by 69% year-on-year and by 33% since the previous quarter

Efficiency

How efficient is Applied Therapeutics business performance
APLT's return on invested capital has dropped by 135% year-on-year and by 65% since the previous quarter
The return on equity has declined by 46% year-on-year and by 29% since the previous quarter
The return on assets has declined by 29% year-on-year and by 21% since the previous quarter

Dividends

What is APLT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for APLT.

Financial health

How did Applied Therapeutics financials performed over time
The company's total assets is 183% higher than its total liabilities
The quick ratio has dropped by 67% year-on-year and by 18% since the previous quarter
The current ratio has plunged by 63% YoY and by 14% from the previous quarter
APLT's debt is 97% smaller than its equity
The company's debt to equity has surged by 200% YoY and by 50% QoQ
The equity has dropped by 69% year-on-year and by 33% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.